Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure
- PMID: 16162155
- DOI: 10.1111/j.1478-3231.2005.01091.x
Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure
Abstract
Rationale: Fulminant liver failure from drug ingestion is associated with a high mortality, and the introduction of liver transplantation has improved the mortality significantly if done in a timely fashion. Recently, molecular adsorbent recycling system (MARS) liver dialysis has been introduced as a support for liver failure with varying results. We review our experience with drug-induced liver failure and the impact of MARS liver dialysis on the outcome, in a setting where cadaveric liver transplantation is rarely available.
Results: A total of 13 patients were treated, and 40 sessions of MARS liver dialysis were conducted in the intensive care unit. The majority of cases were because of herbal medicine toxicity. Total bilirubin, conjugated bilirubin, and delta bilirubin were significantly reduced, with no change in unconjugated bilirubin. All patients satisfied the criteria for urgent liver transplantation with an average Model End Stage Liver Disease (MELD) score of 35. Only one patient received a liver transplantation from a live donor (right lobe). Overall mortality was 85%. Median time-to-death from the start of MARS was 8 days.
Conclusions: MARS liver dialysis in a setting without timely liver transplantation is associated with a poor outcome. It does, however, provide a window of time for consideration of living donors in the setting of limited cadaveric donors.
Similar articles
-
Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.Crit Care. 2007;11(3):215. doi: 10.1186/cc5922. Crit Care. 2007. PMID: 17567927 Free PMC article. Review.
-
MARS dialysis in decompensated alcoholic liver disease: a single-center experience.Liver Transpl. 2007 Aug;13(8):1189-92. doi: 10.1002/lt.21235. Liver Transpl. 2007. PMID: 17663393
-
Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.Transplant Proc. 2005 Jul-Aug;37(6):2547-50. doi: 10.1016/j.transproceed.2005.06.048. Transplant Proc. 2005. PMID: 16182739
-
Pediatric acute liver failure with molecular adsorbent recirculating system treatment.Transplant Proc. 2008 Jul-Aug;40(6):1921-4. doi: 10.1016/j.transproceed.2008.05.075. Transplant Proc. 2008. PMID: 18675090
-
Liver support technology--an update.Xenotransplantation. 2006 Sep;13(5):380-9. doi: 10.1111/j.1399-3089.2006.00323.x. Xenotransplantation. 2006. PMID: 16925661 Review.
Cited by
-
Evaluating the Effect of Artificial Liver Support on Acute-on-Chronic Liver Failure Using the Quantitative Difference Algorithm: Retrospective Study.JMIR Form Res. 2023 Oct 24;7:e45395. doi: 10.2196/45395. JMIR Form Res. 2023. PMID: 37874632 Free PMC article.
-
Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".J Clin Exp Hepatol. 2016 Mar;6(1):26-32. doi: 10.1016/j.jceh.2015.08.002. Epub 2015 Aug 19. J Clin Exp Hepatol. 2016. PMID: 27194893 Free PMC article.
-
Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.Crit Care. 2007;11(3):215. doi: 10.1186/cc5922. Crit Care. 2007. PMID: 17567927 Free PMC article. Review.
-
Epidemiology of acute liver failure.Curr Gastroenterol Rep. 2007 Mar;9(1):66-73. doi: 10.1007/s11894-008-0023-x. Curr Gastroenterol Rep. 2007. PMID: 17335680 Review.
-
Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure.Int J Med Sci. 2019 Mar 9;16(3):461-469. doi: 10.7150/ijms.30424. eCollection 2019. Int J Med Sci. 2019. PMID: 30911280 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous